Trials / Terminated
TerminatedNCT03502161
Clinical Evaluation of the QuantiFERON CMV Assay
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- QIAGEN Gaithersburg, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Validate the use of the device in the clinical setting for assessing the risk of CMV Infection in SOT recipients after the completion of antiviral prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | QuantiFERON CMV Assay | Assay to measure cell-mediated immune function using QuantiFERON CMV assay. |
Timeline
- Start date
- 2018-11-15
- Primary completion
- 2020-05-15
- Completion
- 2020-06-30
- First posted
- 2018-04-18
- Last updated
- 2020-09-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03502161. Inclusion in this directory is not an endorsement.